CD8 T Cell Epitope Generation Toward the Continually Mutating SARS-CoV-2 Spike Protein in Genetically Diverse Human Population: Implications for Disease Control and Prevention
Overview
Authors
Affiliations
The ongoing pandemic of SARS-CoV-2 has brought tremendous crisis on global health care systems and industrial operations that dramatically affect the economic and social life of numerous individuals worldwide. Understanding anti-SARS-CoV-2 immune responses in population with different genetic backgrounds and tracking the viral evolution are crucial for successful vaccine design. In this study, we reported the generation of CD8 T cell epitopes by a total of 80 alleles of three major class I HLAs using NetMHC 4.0 algorithm for the SARS-CoV-2 spike protein, which can be targeted by both B cells and T cells. We found diverse capacities of S protein specific epitope presentation by different HLA alleles with very limited number of predicted epitopes for HLA-B*2705, HLA-B*4402 and HLA-B*4403 and as high as 132 epitopes for HLA-A*6601. Our analysis of 1000 S protein sequences from field isolates collected globally over the past few months identified three recurrent point mutations including L5F, D614G and G1124V. Differential effects of these mutations on CD8 T cell epitope generation by corresponding HLA alleles were observed. Finally, our multiple alignment analysis indicated the absence of seasonal CoV induced cross-reactive CD8 T cells to drive these mutations. Our findings suggested that individuals with certain HLA alleles, such as B*44 are more prone to SARS-CoV-2 infection. Studying anti-S protein specific CD8 T cell immunity in diverse genetic background is critical for better control and prevention of the SARS-CoV-2 pandemic.
Mota G, Marques C, Ribeiro S, Albuquerque C, Castro G, Fernandino D Adv Rheumatol. 2023; 63(1):56.
PMID: 38031143 DOI: 10.1186/s42358-023-00340-0.
Equestre M, Marcantonio C, Marascio N, Centofanti F, Martina A, Simeoni M Microorganisms. 2023; 11(11).
PMID: 38004723 PMC: 10672769. DOI: 10.3390/microorganisms11112711.
CD8 T-cell immune escape by SARS-CoV-2 variants of concern.
Kombe Kombe A, Biteghe F, Ndoutoume Z, Jin T Front Immunol. 2022; 13:962079.
PMID: 36389664 PMC: 9647062. DOI: 10.3389/fimmu.2022.962079.
Raheja H, Das S, Banerjee A, P D, C D, Mukhopadhyay D Microbiol Spectr. 2022; 10(4):e0078122.
PMID: 35862952 PMC: 9430728. DOI: 10.1128/spectrum.00781-22.
Fibke C, Joffres Y, Tyson J, Colijn C, Janjua N, Fjell C Front Public Health. 2022; 10:915363.
PMID: 35859775 PMC: 9289444. DOI: 10.3389/fpubh.2022.915363.